PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
CRH plc (CRH)
114.271.68 (1.49%)
111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-23.83%
Revenue decline while USLM shows 13.98% growth. Joel Greenblatt would examine competitive position erosion.
-13.85%
Cost reduction while USLM shows 1.06% growth. Joel Greenblatt would examine competitive advantage.
-41.87%
Gross profit decline while USLM shows 30.24% growth. Joel Greenblatt would examine competitive position.
-23.68%
Margin decline while USLM shows 14.27% expansion. Joel Greenblatt would examine competitive position.
No Data
No Data available this quarter, please select a different quarter.
-5.17%
G&A reduction while USLM shows 0.00% growth. Joel Greenblatt would examine efficiency advantage.
No Data
No Data available this quarter, please select a different quarter.
-113.73%
Other expenses reduction while USLM shows 0.00% growth. Joel Greenblatt would examine efficiency.
-11.53%
Operating expenses reduction while USLM shows 43.89% growth. Joel Greenblatt would examine advantage.
-13.24%
Total costs reduction while USLM shows 4.87% growth. Joel Greenblatt would examine advantage.
13.13%
Interest expense change of 13.13% while USLM maintains costs. Bruce Berkowitz would investigate control.
-11.83%
D&A reduction while USLM shows 1.54% growth. Joel Greenblatt would examine efficiency.
-70.87%
EBITDA decline while USLM shows 23.97% growth. Joel Greenblatt would examine position.
-59.43%
EBITDA margin decline while USLM shows 8.77% growth. Joel Greenblatt would examine position.
-98.37%
Operating income decline while USLM shows 28.33% growth. Joel Greenblatt would examine position.
-97.86%
Operating margin decline while USLM shows 12.59% growth. Joel Greenblatt would examine position.
-40.17%
Other expenses reduction while USLM shows 0.59% growth. Joel Greenblatt would examine advantage.
-114.79%
Pre-tax income decline while USLM shows 25.83% growth. Joel Greenblatt would examine position.
-119.42%
Pre-tax margin decline while USLM shows 10.40% growth. Joel Greenblatt would examine position.
-140.56%
Tax expense reduction while USLM shows 23.74% growth. Joel Greenblatt would examine advantage.
-112.82%
Net income decline while USLM shows 26.39% growth. Joel Greenblatt would examine position.
-116.84%
Net margin decline while USLM shows 10.89% growth. Joel Greenblatt would examine position.
-114.56%
EPS decline while USLM shows 26.60% growth. Joel Greenblatt would examine position.
-114.71%
Diluted EPS decline while USLM shows 26.60% growth. Joel Greenblatt would examine position.
-0.25%
Share count reduction while USLM shows 0.00% change. Joel Greenblatt would examine strategy.
-1.02%
Diluted share reduction while USLM shows 0.07% change. Joel Greenblatt would examine strategy.